EU DECISIONS ON THE CONTROL OF NEW PSYCHOACTIVE SUBSTANCES

EU Council Decision 2018/747/EU deals with N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA). 

EU Council Decision 2018/748/EU deals with 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA).

ADB-CHMINACA and CUMYL-4CN-BINACA are synthetic cannabinoids with similar effects to those of THC, which is responsible for the major psychoactive effects of cannabis, but they have additional life-threatening toxicity.  The Decisions follow a risk assessment report on each of the new psychoactive substances and require control measures to be put into effect across the EU, as provided for under their national legislation, in compliance with their obligations under the 1971 UN Convention on Psychotropic Substances, and by 23^rd May 2019.

http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv:OJ.L_.2018.125.01.0008.01.ENG&toc=OJ:L:2018:125:TOC

http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv:OJ.L_.2018.125.01.0010.01.ENG&toc=OJ:L:2018:125:TOC

Author: raytodd2017

Chartered Legal Executive and former senior manager with Isle of Man Customs and Excise, where I was (amongst other things) Sanctions Officer (for UN/EU sanctions), Export Licensing Officer and Manager of the Legal-Library & Collectorate Support Section View all posts by raytodd2017